ZALCITABINE (DDC)-ORAL, HIVID

1. HIV AIDS Myths and Facts Slideshow Pictures
2. Take the HIV/AIDS Quiz
3. AIDS Retrospective Slideshow Pictures

GENERIC NAME: ZALCITABINE (DDC) - ORAL (zal-SITE-uh-bean)

BRAND NAME(S): HIVID

Warning | Medication Uses | How To Use | Side Effects | Precautions | Drug Interactions | Overdose | Notes | Missed Dose | Storage | Medical Alert

WARNING: This drug may infrequently cause severe side effects which sometimes could be fatal. Zalcitabine can cause severe nerve problems (peripheral neuropathy), and should be used with extreme caution in those who already suffer from this disorder. It may rarely cause swelling of the pancreas (pancreatitis). Tell your doctor immediately if vomiting, stomach/abdominal pain, or persistent nausea occur, as this drug may be stopped until you can be checked. A metabolic disorder (lactic acidosis) as well as severe liver disease may also occur. Rarely, fatal liver failure has occurred in those with hepatitis B infection while using zalcitabine. It should be used with caution if you have a hepatitis B infection. Tell your doctor immediately if tingling/numbness of the hands and feet, dark urine, yellowing of eyes/skin, rapid breathing, muscle aches, or unusual drowsiness occur.

Report Problems to the Food and Drug Administration You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088. Need help identifying pills and medications? Use the pill identifier tool on RxList.